Is Can-Fite BioPharma Ltd. (CANF) a Buy, Sell, or Hold?
AMEX : CANF
Can-Fite BioPharma Ltd. — Analyst Ratings
$3.44 USD
-$0.12 (-3.37%)
- Volume
- 28.72K
- Average Volume
- 1.45M
- Market Capitalization
- $4.5M
- P/E Ratio
- -0.77
- Dividend Yield
- 0.00%
- Price Target
- $8.00
- Year High
- $14.00
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.46
Analyst Consensus Summary
Consensus Rating
Sell
4 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-57.0%
vs Current Price
Price Target
$8.00
Average TargetPrice Target Range
Lowest Target
$8.00
-57.0% DOWNSIDE
Average Target
$8.00
Median Estimate
Highest Target
$8.00
-57.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 4
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 3 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Swayampakula Ramakanth | $5 | $3.36 | 2026-05-12 06:14 AM | 48.8% |
| Industrial Alliance Securities | James Molloy | $4.5 | $31.4 | 2025-04-15 07:02 AM | -85.7% |
| EF Hutton | Jason Kolbert | $10 | $73.2 | 2024-07-17 03:06 AM | -86.3% |